Cargando…

Nonlinear mixed-effects modelling for single cell estimation: when, why, and how to use it

BACKGROUND: Studies of cell-to-cell variation have in recent years grown in interest, due to improved bioanalytical techniques which facilitates determination of small changes with high uncertainty. Like much high-quality data, single-cell data is best analysed using a systems biology approach. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson, Markus, Janzén, David L.I., Durrieu, Lucia, Colman-Lerner, Alejandro, Kjellsson, Maria C., Cedersund, Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559169/ https://www.ncbi.nlm.nih.gov/pubmed/26335227 http://dx.doi.org/10.1186/s12918-015-0203-x

Ejemplares similares

Characterization of cell-to-cell variation in nuclear transport rates and identification of its sources
por: Durrieu, Lucía, et al.
Publicado: (2022)

A method for zooming of nonlinear models of biochemical systems
por: Sunnåker, Mikael, et al.
Publicado: (2011)

Why, when and how to update a meta-ethnography qualitative synthesis
por: France, Emma F., et al.
Publicado: (2016)

Combining test statistics and models in bootstrapped model rejection: it is a balancing act
por: Johansson, Rikard, et al.
Publicado: (2014)

Zooming of states and parameters using a lumping approach including back-translation
por: Sunnåker, Mikael, et al.
Publicado: (2010)

A practical guide to estimating the light extinction coefficient with nonlinear models—a case study on maize
por: Lacasa, Josefina, et al.
Publicado: (2021)

Assessing scalability of an intervention: why, how and who?
por: Zamboni, Karen, et al.
Publicado: (2019)

Detecting outliers when fitting data with nonlinear regression – a new method based on robust nonlinear regression and the false discovery rate
por: Motulsky, Harvey J, et al.
Publicado: (2006)

Novel metaheuristic for parameter estimation in nonlinear dynamic biological systems
por: Rodriguez-Fernandez, Maria, et al.
Publicado: (2006)

Not if but when; no longer why but how
por: Piper, Ian
Publicado: (2007)

Combining accelerometry with allometry for estimating daily energy expenditure in joules when in-lab calibration is unavailable
por: Chakravarty, Pritish, et al.
Publicado: (2023)

How to assess success of treatment when using multiple doses: the case of misoprostol for medical abortion
por: Seuc, Armando H., et al.
Publicado: (2015)

When Apnea Turns Terminal: When, How, Why?
por: Goldman, Alica M.
Publicado: (2021)

Survival Analysis: Where, Why, What and How?
por: Indrayan, Abhaya, et al.
Publicado: (2021)

Estimating risk factor attributable burden – challenges and potential solutions when using the comparative risk assessment methodology
por: Plass, Dietrich, et al.
Publicado: (2022)

Birth Control: Why, When and How?
Publicado: (1940)

Loss of Migraine: When, Why and How
por: Blau, J. N.
Publicado: (1987)

Surgical Stillness—When, Why, and How?
por: Rosenberg, Jacob, et al.
Publicado: (2019)

Research Funding—Why, When, and How?
por: Neema, Shekhar, et al.
Publicado: (2021)

Immunotherapy in myeloma: Why, when and how?
por: van de Donk, Niels W.C.J.
Publicado: (2018)

Sarcopenia: how to measure, when and why
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2022)

Calcifediol: Why, When, How Much?
por: Donati, Simone, et al.
Publicado: (2023)

Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging
por: Karlsson, Markus, et al.
Publicado: (2023)

Mitotic Recombination: Why? When? How? Where?
por: LaFave, Matthew C., et al.
Publicado: (2009)

N-acetylcysteine in COPD: why, how, and when?
por: Sanguinetti, Claudio M.
Publicado: (2016)

Cardiac papillary fibroelastoma; when, how, why?
por: Baikoussis, Nikolaos G., et al.
Publicado: (2016)

Adapting improvements to context: when, why and how?
por: Ovretveit, John, et al.
Publicado: (2018)

Pediatric eye screening – Why, when, and how
por: Honavar, Santosh G
Publicado: (2018)

The why, when, and how of computing in biology classrooms
por: Wright, April M., et al.
Publicado: (2020)

Adapting improvements to context: when, why and how?
por: Ovretveit, John, et al.
Publicado: (2018)

Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021)

Cancer-associated thrombosis: the when, how and why
por: Fernandes, Caio J., et al.
Publicado: (2019)

ESSKA consensus initiative: why, when and how?
por: Beaufils, Philippe, et al.
Publicado: (2023)

Preemptive kidney transplantation: why, when, and how?
por: Moura, Ana Flávia, et al.
Publicado: (2022)

A New Procedure to Assess When Estimates from the Cumulative Link Model Can Be Interpreted as Differences for Ordinal Scales in Quality of Life Studies
por: Ning, Yilin, et al.
Publicado: (2021)

Why is greater medication adherence associated with better outcomes
por: Hartz, Arthur, et al.
Publicado: (2013)

How Poor Is Your Sample? A Simple Approach for Estimating the Relative Economic Status of Small and Nonrepresentative Samples
por: Ostermann, Jan, et al.
Publicado: (2023)

Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?
por: Mukaka, Mavuto, et al.
Publicado: (2016)

Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling
por: Dosne, Anne-Gaëlle, et al.
Publicado: (2016)

Restoration of Noncarious Cervical Lesions: When, Why, and How
por: Perez, Cesar dos Reis, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ntqrpasqu1g07qdch8qef2in0o